FindTrial
Sign In

Management of Renal calculi with Shankhdrav.

THE EFFICACY OF SHANKHADRAV IN THE MANAGEMENT OF MOOTRASHMARI WITH SPECIAL REFERENCE TO UROLITHIASIS A RANDOMIZED CONTROLLED TRIAL - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/085995
Enrollment
60
Registered
2025-04-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N23- Unspecified renal colic

Interventions

None listed

Sponsors

Dr Vilas Eknath Koli
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient presenting with sign and symptoms of Mootrashmari. 2. Patients with size of calculus from 5mm to 12 mm. 3. Patients having calculus at Kidney, Ureter, Bladder. 4. Patients between age 18 to 60 years. 5. Patients willing to participate in clinical trial with written consent.

Exclusion criteria

Exclusion criteria: Pregnancy / Lactation Patients not willing to participate in trial. Patients suffering from associated Urolithiasis with following disease will be excluded. Immunocompromised patient. Diabetic patients. Renal failure, congenital disorders like ectopic kidney, horse shoe kidney, stricture at Uretero Vesical & Uretero Pelvic junction, neoplasm. Patients having severe hydronephrosis

Design outcomes

Primary

MeasureTime frame
Decrease in size of urinary calculi with treatment.Timepoint: Up to 45days—

Secondary

MeasureTime frame
Signs and symptoms of Urolithiasis will improve with treatment.Timepoint: Up to 45 days—

Countries

India

Contacts

Public ContactDr Chandrakant Dhanokar

R .T Ayurved Mahavidyalaya , Akola

jagdishdhanokar2010@rediffmail.com9975053354

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026